Laura E Anderson, OD
Optometry · Roseville
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 2
Offices
2 locations · Fyidoctors of California Inc · 21 clinicians in this group
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Anderson’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence C13804 · Cancelled
Licence status: Cancelled · since 1952 · Indiana University School of Medicine.
License has been voluntarily canceled, or the license has been expired for at least five years and has not been renewed. No practice is permitted.
Matched on the licence number without its letter prefix; check the name before relying on it.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$40,376
Medicare paid this office $40,376 for 267 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Established patient complete exam of visual system | 194 | $19,094 | $96 |
| Exam of visual field with extended testing | 115 | $6,139 | $49 |
| New patient complete exam of visual system | 42 | $4,334 | $103 |
| Imaging of retina | 77 | $2,475 | $31 |
| Photography of the retina | 48 | $1,501 | $29 |
See all 8 services
| Established patient complete exam of visual system | 194 | $19,094 | $96 |
| Exam of visual field with extended testing | 115 | $6,139 | $49 |
| New patient complete exam of visual system | 42 | $4,334 | $103 |
| Imaging of retina | 77 | $2,475 | $31 |
| Photography of the retina | 48 | $1,501 | $29 |
| Established patient problem focused exam of visual system | 22 | $1,462 | $66 |
| Imaging of optic nerve | 35 | $1,261 | $29 |
| Short return visit (20+ min) | 16 | $1,236 | $69 |
Procedures Medicare counted
| Cataract surgery | 11 | More than 32% of doctors who do this |
Who their Medicare patients are
267 Original Medicare patients in 2024. Average age 74 · Women 54% · Also on Medicaid 16% · Health risk score 0.79. At or below the middle of the specialty; the typical optometry clinician is at 0.97.
Conditions among them: High blood pressure 52% · Chronic kidney disease 14% · Diabetes 13% · Coronary heart disease 13% · Cancer 13% · Atrial fibrillation 12% · Depression 12% · COPD 7% · Heart failure 6% · Stroke 6%.
The office billed $82,530, Medicare allowed $57,572 and paid $40,376; for 623 services of 18 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 267 | 623 | 74 | 0.79 | $82,530 | $40,376 |
| 2023 | 249 | 594 | 74 | 0.88 | $75,502 | $33,724 |
| 2022 | 378 | 558 | 73 | 1.15 | $88,936 | $39,536 |
| 2021 | 309 | 495 | 72 | 1.14 | $76,578 | $33,831 |
| 2020 | 258 | 372 | 72 | 1.14 | $59,441 | $27,796 |
| 2019 | 285 | 472 | 73 | 1.14 | $76,222 | $35,629 |
| 2018 | 142 | 218 | 73 | 0.98 | $35,506 | $17,339 |
| 2017 | 175 | 228 | 73 | 1.25 | $35,262 | $15,338 |
| 2016 | 145 | 174 | 73 | 1.01 | $27,570 | $13,795 |
| 2015 | 79 | 99 | 75 | 0.97 | $16,254 | $9,152 |
| 2014 | 40 | 47 | 71 | 1.01 | $6,925 | $4,143 |
| 2013 | 30 | 34 | 71 | 1.22 | $4,655 | $2,651 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 8 services
| Established patient complete exam of visual system | 137 | $11,608 | $83 |
| New patient complete exam of visual system | 63 | $6,075 | $96 |
| Exam of visual field with extended testing | 111 | $5,453 | $47 |
| Established patient problem focused exam of visual system | 50 | $3,826 | $68 |
| Imaging of retina | 81 | $2,491 | $29 |
| Photography of the retina | 38 | $1,238 | $30 |
| Imaging of optic nerve | 30 | $943 | $29 |
| Photography of content of eyes | 26 | $494 | $18 |
2022: 6 services
| Established patient complete exam of visual system | 212 | $19,928 | $89 |
| New patient complete exam of visual system | 76 | $7,750 | $102 |
| Established patient problem focused exam of visual system | 61 | $4,373 | $66 |
| Imaging of retina | 128 | $4,053 | $30 |
| Imaging of optic nerve | 31 | $873 | $27 |
| Exam of visual field with extended testing | 13 | $652 | $50 |
2021: 6 services
| Established patient complete exam of visual system | 168 | $15,785 | $89 |
| New patient complete exam of visual system | 77 | $7,772 | $101 |
| Established patient problem focused exam of visual system | 65 | $4,889 | $67 |
| Imaging of retina | 102 | $3,266 | $31 |
| Exam of visual field with extended testing | 19 | $1,047 | $50 |
| Imaging of optic nerve | 29 | $760 | $25 |
2020: 6 services
| Established patient complete exam of visual system | 143 | $14,047 | $95 |
| New patient complete exam of visual system | 54 | $5,228 | $97 |
| Established patient problem focused exam of visual system | 43 | $3,225 | $67 |
| Imaging of retina | 68 | $2,313 | $32 |
| Exam of visual field with extended testing | 13 | $575 | $44 |
| Imaging of optic nerve | 18 | $482 | $27 |
2019: 6 services
| Established patient complete exam of visual system | 155 | $15,164 | $92 |
| New patient complete exam of visual system | 71 | $7,834 | $110 |
| Established patient problem focused exam of visual system | 54 | $4,684 | $66 |
| Imaging of retina | 81 | $2,669 | $32 |
| Imaging of optic nerve | 38 | $1,026 | $27 |
| Exam of visual field with extended testing | 14 | $554 | $37 |
2018: 5 services
| Established patient complete exam of visual system | 81 | $8,322 | $98 |
| Established patient problem focused exam of visual system | 30 | $2,435 | $72 |
| New patient complete exam of visual system | 13 | $1,453 | $112 |
| Imaging of retina | 39 | $1,369 | $35 |
| Imaging of optic nerve | 21 | $524 | $25 |
2017: 5 services
| Established patient complete exam of visual system | 101 | $8,757 | $86 |
| Established patient problem focused exam of visual system | 40 | $2,921 | $66 |
| New patient complete exam of visual system | 25 | $1,871 | $75 |
| Imaging of retina | 18 | $550 | $31 |
| Imaging of optic nerve | 20 | $479 | $24 |
2016: 4 services
| Established patient complete exam of visual system | 80 | $7,753 | $97 |
| New patient complete exam of visual system | 34 | $3,078 | $91 |
| Established patient problem focused exam of visual system | 27 | $1,798 | $64 |
| Imaging of optic nerve | 11 | $387 | $35 |
2015: 2 services
| Established patient complete exam of visual system | 39 | $3,783 | $97 |
| New patient complete exam of visual system | 28 | $2,821 | $101 |
2014: 2 services
| Established patient complete exam of visual system | 17 | $1,615 | $95 |
| Established patient problem focused exam of visual system | 11 | $787 | $72 |
2013: 1 service
| Established patient complete exam of visual system | 13 | $1,127 | $87 |
Medicaid work
$0 in 2024
Medicaid paid $0 for 1,339 billed services this clinician did in 2024, up to 69 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| OPH SVCS MEDICAL XM&EVAL COMPRE NEW PT 1/> VST | 225 | $0 |
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 190 | $0 |
| DETERMINATION REFRACTIVE STATE | 433 | $0 |
| Fitting of monofocal spectacles | 159 | $0 |
| Frames, purchases | 332 | $0 |
| 2024 | 1,339 | 5 | 69 | $0 |
| 2023 | 167 | 3 | 17 | $2,588 |
| 2022 | 426 | 4 | 30 | $4,728 |
| 2021 | 1,148 | 6 | 71 | $19,167 |
| 2020 | 1,521 | 6 | 73 | $23,025 |
| 2019 | 989 | 6 | 53 | $15,042 |
| 2018 | 695 | 3 | 56 | $13,064 |
See the largest Medicaid services in earlier years
2023
| Frames, purchases | 62 | $1,262 |
| Fitting of monofocal spectacles | 45 | $919 |
| DETERMINATION REFRACTIVE STATE | 60 | $407 |
2022
| OPH SVCS MEDICAL XM&EVAL COMPRE NEW PT 1/> VST | 87 | $2,265 |
| DETERMINATION REFRACTIVE STATE | 242 | $1,571 |
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 70 | $892 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina | 27 | $0 |
2021
| OPH SVCS MEDICAL XM&EVAL COMPRE NEW PT 1/> VST | 193 | $5,900 |
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 183 | $4,924 |
| Frames, purchases | 148 | $2,900 |
| DETERMINATION REFRACTIVE STATE | 479 | $2,854 |
| Fitting of monofocal spectacles | 132 | $2,589 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina | 13 | $0 |
2020
| OPH SVCS MEDICAL XM&EVAL COMPRE NEW PT 1/> VST | 319 | $7,586 |
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 237 | $4,952 |
| Frames, purchases | 205 | $4,016 |
| Fitting of monofocal spectacles | 183 | $3,641 |
| DETERMINATION REFRACTIVE STATE | 563 | $2,830 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina | 14 | $0 |
2019
| OPH SVCS MEDICAL XM&EVAL COMPRE NEW PT 1/> VST | 245 | $6,230 |
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 208 | $5,033 |
| DETERMINATION REFRACTIVE STATE | 491 | $2,658 |
| Routine ophthalmological examination including refraction; new patient | 12 | $542 |
| Frames, purchases | 16 | $294 |
| Fitting of monofocal spectacles | 17 | $284 |
2018
| OPH SVCS MEDICAL XM&EVAL COMPRE NEW PT 1/> VST | 224 | $8,001 |
| DETERMINATION REFRACTIVE STATE | 405 | $2,720 |
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 66 | $2,343 |
Drugs they prescribed that Part D paid
$19,134
Pharmacies billed $19,134 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 173) in 2024. At or below the middle of the specialty; the typical optometry clinician is at 0%.
65 generic and 108 brand-name prescriptions · $19,134 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Xiidra | 13 | $8,351 | $642 |
| Rhopressa | 13 | $3,980 | $306 |
| Lumigan | 11 | $3,196 | $291 |
| Latanoprost | 95 | $722 | $8 |
| Azelastine | 11 | $546 | $50 |
Year by year
| 2024 | 173 | 33 | 0% (0) | 62% | $19,134 |
| 2023 | 203 | 69 | 0% (0) | 62% | $63,306 |
| 2022 | 300 | 98 | 0% (0) | 57% | $90,926 |
| 2021 | 217 | 76 | 0% (0) | 54% | $63,410 |
| 2020 | 103 | 43 | 0% (0) | 41% | $20,826 |
| 2019 | 121 | 52 | 0% (0) | 41% | $19,682 |
| 2018 | 59 | 29 | 0% (0) | 56% | $7,473 |
| 2017 | 65 | 27 | 0% (0) | 57% | $10,444 |
| 2016 | 20 | 13 | 0% (0) | 70% | $4,664 |
| 2014 | 12 | None | 0% (0) | None | $761 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 6 drugs
| Restasis | 14 | $18,271 | $1,305 |
| Xiidra | 11 | $11,018 | $1,002 |
| Lumigan | 26 | $7,136 | $274 |
| Timolol Maleate | 15 | $1,625 | $108 |
| Latanoprost | 68 | $1,351 | $20 |
| Azelastine | 11 | $308 | $28 |
2022: 7 drugs
| Restasis | 24 | $39,022 | $1,626 |
| Lumigan | 40 | $11,420 | $286 |
| Timolol Maleate | 29 | $2,343 | $81 |
| Latanoprost | 69 | $1,372 | $20 |
| Azelastine | 25 | $1,323 | $53 |
| Prednisolone Acetate | 13 | $476 | $37 |
| Cromolyn | 11 | $137 | $12 |
2021: 5 drugs
| Restasis | 24 | $29,505 | $1,229 |
| Cequa | 13 | $19,057 | $1,466 |
| Lumigan | 20 | $4,485 | $224 |
| Azelastine | 28 | $1,204 | $43 |
| Latanoprost | 53 | $886 | $17 |
2020: 3 drugs
| Restasis | 11 | $16,212 | $1,474 |
| Azelastine | 17 | $950 | $56 |
| Latanoprost | 32 | $617 | $19 |
2019: 4 drugs
| Olopatadine | 17 | $995 | $59 |
| Azelastine | 13 | $588 | $45 |
| Latanoprost | 12 | $343 | $29 |
| Neomycin-Polymyxin-Dexameth | 12 | $143 | $12 |
2017: 2 drugs
| Pataday | 13 | $2,529 | $195 |
| Olopatadine | 12 | $1,824 | $152 |
Money from drug and device companies
$67 in 2025
| 2025 | 1 | 2 | None | $67 |
| 2024 | 2 | 4 | None | $132 |
| 2023 | 2 | 2 | None | $58 |
| 2022 | 5 | 24 | None | $469 |
| 2021 | 6 | 14 | None | $255 |
| 2020 | 7 | 8 | None | $232 |
| 2019 | 4 | 9 | None | $167 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Bausch & Lomb Americas | Infuse | $67 | 2 payments
|
See all 2 published payments
| Bausch & Lomb Americas | Meals · 2025-11-13 | Infuse | $44 |
| Bausch & Lomb Americas | Meals · 2025-04-30 | Infuse | $23 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $132
| Bausch & Lomb Americas | Infuse | $66 | 2 payments
|
| Johnson & Johnson Vision Care | None | $66 | 2 payments
|
2023: $58
| Bausch & Lomb Americas | Infuse | $29 | 1 payment
|
| Novartis Pharmaceuticals | Xiidra | $29 | 1 payment
|
2022: $469
| Novartis Pharmaceuticals | Xiidra | $260 | 14 payments
|
| Sun Pharmaceutical Industries | Cequa | $89 | 4 payments
|
| Alcon Vision | Rhopressa | $45 | 2 payments
|
| Oyster Point Pharma | Tyrvaya | $40 | 2 payments
|
| Dompe US | Oxervate | $35 | 2 payments
|
2021: $255
| Sun Pharmaceutical Industries | Cequa | $131 | 7 payments
|
| Aerie Pharmaceuticals | Rhopressa | $38 | 2 payments
|
| Tissuetech | Prokera | $30 | 2 payments
|
| Novartis Pharmaceuticals | Xiidra | $22 | 1 payment
|
| Dompe US | Oxervate | $22 | 1 payment
|
| Bausch & Lomb a division of Bausch Health US | Prolensa | $12 | 1 payment
|
2020: $232
| Alcon Vision | Acrysof | $73 | 1 payment
|
| Aerie Pharmaceuticals | Rocklatan | $48 | 2 payments
|
| TissueTech | Prokera | $33 | 1 payment
|
| CooperVision | Clariti Contact Lens | $24 | 1 payment
|
| Sun Pharmaceutical Industries | Bromsite | $20 | 1 payment
|
| Allergan | Durysta | $19 | 1 payment
|
| Bausch & Lomb a division of Bausch Health US | Vyzulta | $15 | 1 payment
|
2019: $167
| Bausch & Lomb a division of Bausch Health US | Envista | $79 | 4 payments
|
| Sun Pharmaceutical Industries | Cequa | $39 | 2 payments
|
| Aerie Pharmaceuticals | Rhopressa | $31 | 2 payments
|
| Novartis Pharmaceuticals | Durezol | $19 | 1 payment
|
Professional record
- NPI
- 1962632372
- Licence
- CA 13804California C13804: Cancelled
- Trained
- Pacific University - College of Optometry, 2009
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 152W00000X (152W00000X)
- Mailing address
- 1524 Eureka Rd, Suite 100, Roseville, CA, 95661
- NPI first listed
- 2009-07-20
- NPI last updated
- 2013-07-25
This is when the NPI record was last certified, not a medical board exam.